High Dose-Rate Tandem and Ovoid Brachytherapy in Cervical Cancer: Dosimetric Predictors of Disease Control and Toxicity

      To investigate the rate of and factors influencing gastrointestinal (GI) and genitourinary (GU) toxicity following high dose-rate (HDR) tandem and ovoid brachytherapy in the treatment of locally advanced cervical cancer.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Brachytherapy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect